Cite
Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell Model
MLA
Turrin, G., et al. Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell Model. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439664434&authtype=sso&custid=ns315887.
APA
Turrin, G., Lo Cascio, E., Giacon, N., Fantinati, A., Cristofori, V., Illuminati, D., Preti, D., Morciano, G., Pinton, P., Agyapong, E. D., Trapella, C., Arcovito, A., Lo Cascio E., Giacon N., & Arcovito A. (ORCID:0000-0002-8384-4844). (2024). Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell Model.
Chicago
Turrin, G., Ettore Lo Cascio, Noah Giacon, A. Fantinati, V. Cristofori, D. Illuminati, D. Preti, et al. 2024. “Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell Model.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439664434&authtype=sso&custid=ns315887.